
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>LLM Training Pipeline & Alignment - Interactive Infographic</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            min-height: 100vh;
            padding: 20px;
        }

        .container {
            max-width: 1400px;
            margin: 0 auto;
        }

        header {
            text-align: center;
            color: white;
            margin-bottom: 40px;
            animation: slideDown 0.8s ease-out;
        }

        header h1 {
            font-size: 3em;
            margin-bottom: 10px;
            text-shadow: 2px 2px 4px rgba(0,0,0,0.3);
        }

        header p {
            font-size: 1.3em;
            opacity: 0.95;
        }

        .content-wrapper {
            background: white;
            border-radius: 20px;
            padding: 40px;
            box-shadow: 0 20px 60px rgba(0,0,0,0.3);
            animation: fadeIn 1s ease-out;
        }

        .tabs {
            display: flex;
            gap: 10px;
            margin-bottom: 30px;
            flex-wrap: wrap;
            border-bottom: 3px solid #f0f0f0;
            padding-bottom: 0;
        }

        .tab-button {
            padding: 15px 30px;
            border: none;
            background: none;
            cursor: pointer;
            font-size: 1.1em;
            font-weight: 600;
            color: #666;
            border-bottom: 4px solid transparent;
            transition: all 0.3s ease;
            position: relative;
            bottom: -3px;
        }

        .tab-button:hover {
            color: #667eea;
            background: #f9f9f9;
            border-radius: 10px 10px 0 0;
        }

        .tab-button.active {
            color: white;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            border-bottom: 4px solid #667eea;
            border-radius: 10px 10px 0 0;
        }

        .tab-content {
            display: none;
            animation: fadeIn 0.5s ease-out;
        }

        .tab-content.active {
            display: block;
        }

        /* STAGE CARDS */
        .stages-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 25px;
            margin: 30px 0;
        }

        .stage-card {
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            border-radius: 15px;
            padding: 25px;
            border-left: 5px solid #667eea;
            transition: all 0.3s ease;
            cursor: pointer;
            position: relative;
            overflow: hidden;
        }

        .stage-card:hover {
            transform: translateY(-10px);
            box-shadow: 0 15px 40px rgba(102, 126, 234, 0.2);
            border-left-color: #764ba2;
        }

        .stage-card.stage-1 {
            border-left-color: #FF6B6B;
            background: linear-gradient(135deg, #FFE5E5 0%, #FFB3B3 100%);
        }

        .stage-card.stage-2 {
            border-left-color: #4ECDC4;
            background: linear-gradient(135deg, #E0F7F6 0%, #B3F0EB 100%);
        }

        .stage-card.stage-3 {
            border-left-color: #FFD93D;
            background: linear-gradient(135deg, #FFF8DC 0%, #FFE6A3 100%);
        }

        .stage-card.stage-4 {
            border-left-color: #A8E6CF;
            background: linear-gradient(135deg, #E8F8F5 0%, #C8F5E6 100%);
        }

        .stage-number {
            display: inline-block;
            width: 40px;
            height: 40px;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-radius: 50%;
            text-align: center;
            line-height: 40px;
            font-weight: bold;
            font-size: 1.2em;
            margin-bottom: 10px;
        }

        .stage-title {
            font-size: 1.4em;
            font-weight: bold;
            color: #333;
            margin-bottom: 15px;
        }

        .stage-description {
            color: #555;
            line-height: 1.6;
            margin-bottom: 15px;
            font-size: 0.95em;
        }

        .stage-math {
            background: rgba(255,255,255,0.7);
            padding: 12px;
            border-radius: 8px;
            margin: 15px 0;
            font-family: 'Courier New', monospace;
            font-size: 0.9em;
            overflow-x: auto;
            color: #d63384;
            font-weight: bold;
        }

        .example-box {
            background: white;
            border-left: 4px solid #667eea;
            padding: 15px;
            margin: 15px 0;
            border-radius: 8px;
            font-size: 0.9em;
        }

        .example-box strong {
            color: #667eea;
        }

        .pros-cons {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 15px;
            margin: 15px 0;
        }

        .pros, .cons {
            padding: 12px;
            border-radius: 8px;
            font-size: 0.9em;
        }

        .pros {
            background: #e8f5e9;
            border-left: 4px solid #4caf50;
        }

        .cons {
            background: #ffebee;
            border-left: 4px solid #f44336;
        }

        .pros::before {
            content: "‚úì Advantages: ";
            font-weight: bold;
            color: #2e7d32;
        }

        .cons::before {
            content: "‚úó Limitations: ";
            font-weight: bold;
            color: #c62828;
        }

        /* PIPELINE COMPARISON */
        .pipeline-table {
            width: 100%;
            border-collapse: collapse;
            margin: 30px 0;
            border-radius: 10px;
            overflow: hidden;
            box-shadow: 0 5px 20px rgba(0,0,0,0.1);
        }

        .pipeline-table th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 20px;
            text-align: left;
            font-weight: 600;
            font-size: 1.05em;
        }

        .pipeline-table td {
            padding: 18px 20px;
            border-bottom: 2px solid #f0f0f0;
        }

        .pipeline-table tr:last-child td {
            border-bottom: none;
        }

        .pipeline-table tr:nth-child(even) {
            background: #f9f9f9;
        }

        .pipeline-table tr:hover {
            background: #f0f4ff;
        }

        /* CHALLENGES SECTION */
        .challenges-container {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 25px;
            margin: 30px 0;
        }

        .challenge-card {
            border-radius: 12px;
            padding: 20px;
            border-left: 5px solid;
            transition: all 0.3s ease;
        }

        .challenge-critical {
            border-left-color: #d32f2f;
            background: linear-gradient(135deg, #ffebee 0%, #ffcdd2 100%);
        }

        .challenge-high {
            border-left-color: #f57c00;
            background: linear-gradient(135deg, #fff3e0 0%, #ffe0b2 100%);
        }

        .challenge-medium {
            border-left-color: #fbc02d;
            background: linear-gradient(135deg, #fffde7 0%, #fff9c4 100%);
        }

        .challenge-card:hover {
            transform: translateY(-8px);
            box-shadow: 0 12px 30px rgba(0,0,0,0.15);
        }

        .challenge-severity {
            display: inline-block;
            padding: 6px 12px;
            border-radius: 20px;
            font-size: 0.85em;
            font-weight: bold;
            margin-bottom: 10px;
            color: white;
        }

        .severity-critical {
            background: #d32f2f;
        }

        .severity-high {
            background: #f57c00;
        }

        .severity-medium {
            background: #fbc02d;
            color: #333;
        }

        .challenge-title {
            font-size: 1.2em;
            font-weight: bold;
            margin-bottom: 10px;
            color: #333;
        }

        .challenge-content {
            font-size: 0.95em;
            color: #555;
            line-height: 1.6;
        }

        /* ALIGNMENT METRICS */
        .metrics-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 25px;
            margin: 30px 0;
        }

        .metric-card {
            background: white;
            border-radius: 12px;
            padding: 25px;
            border: 2px solid #f0f0f0;
            transition: all 0.3s ease;
        }

        .metric-card:hover {
            border-color: #667eea;
            box-shadow: 0 10px 30px rgba(102, 126, 234, 0.15);
        }

        .metric-name {
            font-size: 1.15em;
            font-weight: bold;
            color: #333;
            margin-bottom: 15px;
        }

        .metric-bar-container {
            margin: 15px 0;
        }

        .metric-label {
            display: flex;
            justify-content: space-between;
            font-size: 0.9em;
            color: #666;
            margin-bottom: 8px;
        }

        .metric-bar {
            width: 100%;
            height: 20px;
            background: #f0f0f0;
            border-radius: 10px;
            overflow: hidden;
            position: relative;
        }

        .metric-fill {
            height: 100%;
            background: linear-gradient(90deg, #667eea 0%, #764ba2 100%);
            transition: width 0.8s ease;
            display: flex;
            align-items: center;
            justify-content: flex-end;
            padding-right: 8px;
            color: white;
            font-size: 0.8em;
            font-weight: bold;
        }

        .metric-gap {
            background: #ffcdd2;
            height: 100%;
        }

        .metric-definition {
            font-size: 0.9em;
            color: #666;
            margin-top: 12px;
            line-height: 1.5;
        }

        /* PHARMA EXAMPLES */
        .examples-section {
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            border-radius: 15px;
            padding: 30px;
            margin: 30px 0;
        }

        .examples-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 20px;
            margin: 20px 0;
        }

        .example-item {
            background: white;
            border-radius: 10px;
            padding: 15px;
            border-left: 4px solid #667eea;
        }

        .example-item strong {
            color: #667eea;
            display: block;
            margin-bottom: 8px;
        }

        /* FLOW DIAGRAM */
        .flow-container {
            display: flex;
            align-items: center;
            justify-content: space-around;
            flex-wrap: wrap;
            gap: 20px;
            margin: 40px 0;
            padding: 30px;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            border-radius: 15px;
        }

        .flow-box {
            background: white;
            border: 3px solid;
            border-radius: 10px;
            padding: 20px;
            text-align: center;
            min-width: 150px;
            flex: 1;
            min-height: 120px;
            display: flex;
            flex-direction: column;
            justify-content: center;
        }

        .flow-box.stage-1 { border-color: #FF6B6B; }
        .flow-box.stage-2 { border-color: #4ECDC4; }
        .flow-box.stage-3 { border-color: #FFD93D; }
        .flow-box.stage-4 { border-color: #A8E6CF; }

        .flow-arrow {
            font-size: 2em;
            color: #667eea;
            align-self: center;
        }

        @media (max-width: 768px) {
            .flow-arrow {
                transform: rotate(90deg);
                margin: 10px 0;
            }
            
            .flow-container {
                flex-direction: column;
            }
        }

        .flow-label {
            font-weight: bold;
            color: #333;
            margin-bottom: 8px;
        }

        .flow-desc {
            font-size: 0.85em;
            color: #666;
        }

        /* ANIMATIONS */
        @keyframes slideDown {
            from {
                opacity: 0;
                transform: translateY(-30px);
            }
            to {
                opacity: 1;
                transform: translateY(0);
            }
        }

        @keyframes fadeIn {
            from {
                opacity: 0;
            }
            to {
                opacity: 1;
            }
        }

        /* FOOTER */
        footer {
            text-align: center;
            color: white;
            margin-top: 50px;
            padding: 20px;
            font-size: 0.95em;
        }

        /* PRINT STYLES */
        @media print {
            body {
                background: white;
            }
            
            .container {
                box-shadow: none;
            }
            
            .tabs {
                display: none;
            }
        }

        /* RESPONSIVE */
        @media (max-width: 768px) {
            header h1 {
                font-size: 2em;
            }

            .content-wrapper {
                padding: 20px;
            }

            .stages-grid {
                grid-template-columns: 1fr;
            }

            .pros-cons {
                grid-template-columns: 1fr;
            }

            .tabs {
                flex-direction: column;
            }

            .tab-button {
                width: 100%;
                text-align: left;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <header>
            <h1>üß† LLM Training & Alignment Pipeline</h1>
            <p>Complete Journey from Pretraining to Reinforcement Learning from Human Feedback</p>
        </header>

        <div class="content-wrapper">
            <!-- NAVIGATION TABS -->
            <div class="tabs">
                <button class="tab-button active" onclick="showTab('overview')">üìä Overview</button>
                <button class="tab-button" onclick="showTab('stages')">üéØ 4 Training Stages</button>
                <button class="tab-button" onclick="showTab('detailed')">üìñ Detailed Analysis</button>
                <button class="tab-button" onclick="showTab('challenges')">‚ö†Ô∏è Challenges</button>
                <button class="tab-button" onclick="showTab('alignment')">‚úì Alignment Metrics</button>
                <button class="tab-button" onclick="showTab('pharma')">üíä Pharmaceutical Examples</button>
            </div>

            <!-- TAB 1: OVERVIEW -->
            <div id="overview" class="tab-content active">
                <h2 style="color: #667eea; margin-bottom: 20px; font-size: 2em;">üöÄ Complete LLM Training Pipeline</h2>
                
                <p style="font-size: 1.05em; color: #555; line-height: 1.8; margin-bottom: 20px;">
                    Modern language models go through <strong>4 critical stages</strong> to become safe, helpful, and aligned with human values. 
                    Each stage builds on the previous one, solving specific limitations and unlocking new capabilities.
                </p>

                <div class="flow-container">
                    <div class="flow-box stage-1">
                        <div class="flow-label">Stage 1</div>
                        <div class="flow-desc">Pretraining</div>
                        <div style="margin-top: 8px; font-size: 0.8em; color: #999;">Next-Token Prediction</div>
                    </div>
                    <div class="flow-arrow">‚Üí</div>
                    <div class="flow-box stage-2">
                        <div class="flow-label">Stage 2</div>
                        <div class="flow-desc">SFT</div>
                        <div style="margin-top: 8px; font-size: 0.8em; color: #999;">Expert Demonstrations</div>
                    </div>
                    <div class="flow-arrow">‚Üí</div>
                    <div class="flow-box stage-3">
                        <div class="flow-label">Stage 3</div>
                        <div class="flow-desc">Reward Model</div>
                        <div style="margin-top: 8px; font-size: 0.8em; color: #999;">Preference Learning</div>
                    </div>
                    <div class="flow-arrow">‚Üí</div>
                    <div class="flow-box stage-4">
                        <div class="flow-label">Stage 4</div>
                        <div class="flow-desc">PPO</div>
                        <div style="margin-top: 8px; font-size: 0.8em; color: #999;">Policy Optimization</div>
                    </div>
                </div>

                <h3 style="color: #333; margin-top: 40px; margin-bottom: 20px;">Why All 4 Stages Matter</h3>
                
                <table class="pipeline-table">
                    <thead>
                        <tr>
                            <th>Stage</th>
                            <th>Primary Goal</th>
                            <th>Critical Problem Solved</th>
                            <th>Remaining Gap</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong style="color: #FF6B6B;">Pretraining</strong></td>
                            <td>Learn language patterns from massive text</td>
                            <td>Creates linguistic foundation</td>
                            <td>‚ùå No safety or alignment</td>
                        </tr>
                        <tr>
                            <td><strong style="color: #4ECDC4;">SFT</strong></td>
                            <td>Teach instruction-following from experts</td>
                            <td>Enables safe behaviors</td>
                            <td>‚ùå Limited by expert dataset</td>
                        </tr>
                        <tr>
                            <td><strong style="color: #FFD93D;">Reward Model</strong></td>
                            <td>Learn to rank responses on human preferences</td>
                            <td>Can score novel responses</td>
                            <td>‚ùå Distribution shift problem</td>
                        </tr>
                        <tr>
                            <td><strong style="color: #A8E6CF;">PPO</strong></td>
                            <td>Optimize policy toward high rewards</td>
                            <td>Expert-level aligned performance</td>
                            <td>‚úì Complete!</td>
                        </tr>
                    </tbody>
                </table>
            </div>

            <!-- TAB 2: DETAILED STAGES -->
            <div id="stages" class="tab-content">
                <h2 style="color: #667eea; margin-bottom: 30px; font-size: 2em;">üéØ The 4 Training Stages Explained</h2>

                <div class="stages-grid">
                    <!-- STAGE 1 -->
                    <div class="stage-card stage-1">
                        <div class="stage-number" style="background: linear-gradient(135deg, #FF6B6B 0%, #ee5a52 100%);">1</div>
                        <div class="stage-title">Pretraining</div>
                        <div class="stage-description">
                            Model learns to predict the next token given previous tokens. Trained on billions of words from the internet.
                        </div>
                        <div class="stage-math">Loss = -Œ£ log P(w_t | w_&lt;t)</div>
                        <div class="example-box">
                            <strong>Example:</strong> Given "The patient has fever and", model predicts likely next word: "cough", "fatigue", etc.
                        </div>
                        <div class="pros-cons">
                            <div class="pros">Broad linguistic foundation from massive scale</div>
                            <div class="cons">Generates harmful content, no value alignment</div>
                        </div>
                    </div>

                    <!-- STAGE 2 -->
                    <div class="stage-card stage-2">
                        <div class="stage-number" style="background: linear-gradient(135deg, #4ECDC4 0%, #44adb6 100%);">2</div>
                        <div class="stage-title">SFT</div>
                        <div class="stage-description">
                            Model learns from 10k-100k curated expert demonstrations. Each example shows how to respond to instructions correctly.
                        </div>
                        <div class="stage-math">L_SFT = -E[Œ£ log œÄ(expert_response | instruction)]</div>
                        <div class="example-box">
                            <strong>Example:</strong><br/>
                            Instruction: "Warfarin + NSAIDs dangerous?"<br/>
                            Expert: "Yes. 2-3x bleeding risk. Use acetaminophen instead."
                        </div>
                        <div class="pros-cons">
                            <div class="pros">Teaches instruction-following and safety</div>
                            <div class="cons">Limited by expert dataset size and quality</div>
                        </div>
                    </div>

                    <!-- STAGE 3 -->
                    <div class="stage-card stage-3">
                        <div class="stage-number" style="background: linear-gradient(135deg, #FFD93D 0%, #ffc700 100%);">3</div>
                        <div class="stage-title">Reward Model</div>
                        <div class="stage-description">
                            Model learns to score responses based on 20k human preference comparisons using Bradley-Terry loss.
                        </div>
                        <div class="stage-math">L_RM = -log œÉ(r(y_pref) - r(y_dispref))</div>
                        <div class="example-box">
                            <strong>Example Preference:</strong><br/>
                            Preferred: "eGFR >60: 100%, 30-59: 75%, <30: 50%"<br/>
                            Dispreferred: "Just reduce dose if kidneys are bad"
                        </div>
                        <div class="pros-cons">
                            <div class="pros">Can score novel responses beyond training data</div>
                            <div class="cons">Vulnerable to distribution shift when policy changes</div>
                        </div>
                    </div>

                    <!-- STAGE 4 -->
                    <div class="stage-card stage-4">
                        <div class="stage-number" style="background: linear-gradient(135deg, #A8E6CF 0%, #95dcc4 100%);">4</div>
                        <div class="stage-title">PPO</div>
                        <div class="stage-description">
                            Proximal Policy Optimization: Uses the reward model to actively improve policy while staying close to SFT baseline.
                        </div>
                        <div class="stage-math">L = E[min(r_t¬∑A_t, clip(r_t, 1¬±Œµ)¬∑A_t)] - Œ≤¬∑KL(œÄ||œÄ_ref)</div>
                        <div class="example-box">
                            <strong>Result:</strong> Response quality improves +64% on average over SFT through iterative policy optimization.
                        </div>
                        <div class="pros-cons">
                            <div class="pros">Expert-level aligned performance achieved</div>
                            <div class="cons">Computationally expensive, reward hacking possible</div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- TAB 3: DETAILED ANALYSIS -->
            <div id="detailed" class="tab-content">
                <h2 style="color: #667eea; margin-bottom: 30px; font-size: 2em;">üìñ Deep Dive: Mathematical Foundations</h2>

                <h3 style="color: #333; margin: 30px 0 20px 0;">Stage 1: Pretraining - Next Token Prediction</h3>
                <div style="background: #f9f9f9; padding: 20px; border-left: 4px solid #FF6B6B; border-radius: 8px; margin-bottom: 20px;">
                    <p><strong>Objective:</strong> Minimize cross-entropy loss on predicting next token</p>
                    <p style="font-family: monospace; color: #d63384; margin: 10px 0;">Loss = -Œ£ log P(w_t | w_1, w_2, ..., w_{t-1})</p>
                    <p style="margin-top: 15px;"><strong>Key Insight:</strong> Model learns statistical correlations from training data, but has no concept of safety, truthfulness, or helpfulness. A pretrained model on pharmaceutical text would learn that "warfarin" often co-occurs with "bleeding" without understanding WHY.</p>
                </div>

                <h3 style="color: #333; margin: 30px 0 20px 0;">Stage 2: SFT - Behavioral Cloning</h3>
                <div style="background: #f9f9f9; padding: 20px; border-left: 4px solid #4ECDC4; border-radius: 8px; margin-bottom: 20px;">
                    <p><strong>Objective:</strong> Teach model to mimic expert behavior through supervised learning</p>
                    <p style="font-family: monospace; color: #d63384; margin: 10px 0;">L_SFT = -E[(x,y)~D][Œ£_i log œÄ(y_i | x, y_{<i})]</p>
                    <p style="margin-top: 15px;"><strong>Dataset Example:</strong></p>
                    <ul style="margin-left: 20px; margin-top: 10px;">
                        <li>Input: "Elderly patient on 5 drugs with depression. Antidepressant choice?"</li>
                        <li>Expert: "Avoid tricyclics (anticholinergic risk). Use SSRI or SNRI. Monitor for hyponatremia."</li>
                    </ul>
                    <p style="margin-top: 15px;"><strong>Limitation:</strong> SFT only teaches what's in the dataset. If experts all miss a drug interaction, the model will too. It's "capped" by the quality of expert demonstrations.</p>
                </div>

                <h3 style="color: #333; margin: 30px 0 20px 0;">Stage 3: Reward Model - Bradley-Terry Preference Learning</h3>
                <div style="background: #f9f9f9; padding: 20px; border-left: 4px solid #FFD93D; border-radius: 8px; margin-bottom: 20px;">
                    <p><strong>Objective:</strong> Learn to predict human preferences between two responses</p>
                    <p style="font-family: monospace; color: #d63384; margin: 10px 0;">P(prefer y_w | y_l, x) = œÉ(r(x, y_w) - r(x, y_l))</p>
                    <p style="margin-top: 15px;"><strong>Real Preference Example:</strong></p>
                    <div style="background: white; border: 1px solid #ddd; padding: 15px; margin: 10px 0; border-radius: 8px;">
                        <p><strong>Query:</strong> "Metformin + cirrhosis = safe?"</p>
                        <p style="margin: 10px 0;"><strong style="color: #4caf50;">‚úì Preferred:</strong> "Contraindicated. Severe lactic acidosis risk. Use insulin, GLP-1, SGLT2i instead."</p>
                        <p style="margin: 10px 0;"><strong style="color: #f44336;">‚úó Dispreferred:</strong> "Fine to use. Just monitor kidney function."</p>
                    </div>
                    <p style="margin-top: 15px;"><strong>Key Advantage:</strong> RM can score ANY response, even novel ones the model generates. This breaks the "expert dataset cap" of SFT.</p>
                </div>

                <h3 style="color: #333; margin: 30px 0 20px 0;">Stage 4: PPO - Policy Optimization</h3>
                <div style="background: #f9f9f9; padding: 20px; border-left: 4px solid #A8E6CF; border-radius: 8px; margin-bottom: 20px;">
                    <p><strong>Objective:</strong> Maximize reward while staying close to SFT policy (avoid catastrophic forgetting)</p>
                    <p style="font-family: monospace; color: #d63384; margin: 10px 0; word-break: break-all;">L_PPO = E[min(r_t¬∑A_t, clip(r_t, 1-Œµ, 1+Œµ)¬∑A_t)] - Œ≤¬∑KL(œÄ||œÄ_ref)</p>
                    <p style="margin-top: 15px;"><strong>Why PPO?</strong></p>
                    <ul style="margin-left: 20px; margin-top: 10px;">
                        <li><strong>Clipping:</strong> Prevents overly large policy updates in single step</li>
                        <li><strong>KL Penalty:</strong> Keeps new policy close to SFT baseline, preventing "catastrophic forgetting"</li>
                        <li><strong>Advantage Function:</strong> Only improves actions that lead to good outcomes</li>
                    </ul>
                    <p style="margin-top: 15px;"><strong>Results:</strong> Response quality improves +64% on average (from SFT to PPO)</p>
                </div>
            </div>

            <!-- TAB 4: CHALLENGES -->
            <div id="challenges" class="tab-content">
                <h2 style="color: #667eea; margin-bottom: 30px; font-size: 2em;">‚ö†Ô∏è RLHF Challenges & Solutions</h2>

                <div class="challenges-container">
                    <!-- CHALLENGE 1 -->
                    <div class="challenge-card challenge-critical">
                        <div class="challenge-severity severity-critical">CRITICAL</div>
                        <div class="challenge-title">Reward Hacking</div>
                        <div class="challenge-content">
                            <p style="margin-bottom: 12px;"><strong>Problem:</strong> Policy exploits RM defects rather than genuinely improving.</p>
                            <p style="margin-bottom: 12px;"><strong>Example:</strong> If RM rewards length, model generates verbose repetitive text: "The reason is that the reason is that the reason is..."</p>
                            <p><strong>Solutions:</strong></p>
                            <ul style="margin-left: 20px; margin-top: 8px;">
                                <li>Human validation of PPO outputs</li>
                                <li>Ensemble reward models (average 3-5 RMs)</li>
                                <li>Strong KL regularization (high Œ≤)</li>
                                <li>Red-teaming to find exploits</li>
                            </ul>
                            <p style="margin-top: 12px; font-weight: bold; color: #d32f2f;">Mitigation Effectiveness: <span style="color: #333;">92%</span></p>
                        </div>
                    </div>

                    <!-- CHALLENGE 2 -->
                    <div class="challenge-card challenge-high">
                        <div class="challenge-severity severity-high">HIGH</div>
                        <div class="challenge-title">Annotation Quality</div>
                        <div class="challenge-content">
                            <p style="margin-bottom: 12px;"><strong>Problem:</strong> Different annotators have conflicting preferences.</p>
                            <p style="margin-bottom: 12px;"><strong>Example:</strong> Annotator A prioritizes safety (specific eGFR cutoffs), Annotator B prioritizes flexibility (alternatives offered).</p>
                            <p><strong>Solutions:</strong></p>
                            <ul style="margin-left: 20px; margin-top: 8px;">
                                <li>Inter-rater reliability threshold (Fleiss' kappa ‚â•0.6)</li>
                                <li>Multi-annotator consensus (2/3 agreement required)</li>
                                <li>Calibration training for annotators</li>
                                <li>Domain expert oversight</li>
                            </ul>
                            <p style="margin-top: 12px; font-weight: bold; color: #f57c00;">Mitigation Effectiveness: <span style="color: #333;">85%</span></p>
                        </div>
                    </div>

                    <!-- CHALLENGE 3 -->
                    <div class="challenge-card challenge-high">
                        <div class="challenge-severity severity-high">HIGH</div>
                        <div class="challenge-title">Distribution Shift</div>
                        <div class="challenge-content">
                            <p style="margin-bottom: 12px;"><strong>Problem:</strong> RM trained on SFT outputs; PPO generates increasingly different responses.</p>
                            <p style="margin-bottom: 12px;"><strong>Example:</strong> RM confident on in-distribution samples but unreliable on novel PPO-generated pharmaceutical advice.</p>
                            <p><strong>Solutions:</strong></p>
                            <ul style="margin-left: 20px; margin-top: 8px;">
                                <li>Active learning: collect preferences on PPO outputs</li>
                                <li>Iterative RM retraining (RM‚ÜíPPO‚ÜíRM cycles)</li>
                                <li>Confidence-calibrated uncertainty</li>
                                <li>Out-of-distribution detection</li>
                            </ul>
                            <p style="margin-top: 12px; font-weight: bold; color: #f57c00;">Mitigation Effectiveness: <span style="color: #333;">78%</span></p>
                        </div>
                    </div>

                    <!-- CHALLENGE 4 -->
                    <div class="challenge-card challenge-medium">
                        <div class="challenge-severity severity-medium">MEDIUM</div>
                        <div class="challenge-title">Scalability</div>
                        <div class="challenge-content">
                            <p style="margin-bottom: 12px;"><strong>Problem:</strong> Expert time is expensive. 50k preferences ‚âà $500k cost (at $200/hr).</p>
                            <p style="margin-bottom: 12px;"><strong>Example:</strong> Pharmacist: 30 min per 10 preferences = 2500 hours for 50k pairs.</p>
                            <p><strong>Solutions:</strong></p>
                            <ul style="margin-left: 20px; margin-top: 8px;">
                                <li>Focus on high-value, diverse examples</li>
                                <li>RM-guided sampling (high-uncertainty pairs)</li>
                                <li>Crowdsourcing with expert validation</li>
                                <li>Transfer learning from other domains</li>
                            </ul>
                            <p style="margin-top: 12px; font-weight: bold; color: #fbc02d;">Mitigation Effectiveness: <span style="color: #333;">80%</span></p>
                        </div>
                    </div>
                </div>
            </div>

            <!-- TAB 5: ALIGNMENT METRICS -->
            <div id="alignment" class="tab-content">
                <h2 style="color: #667eea; margin-bottom: 30px; font-size: 2em;">‚úì Alignment Evaluation Scorecard</h2>
                <p style="color: #666; font-size: 1.05em; margin-bottom: 30px;">
                    Evaluating how well a pharmaceutical LLM aligns with human expectations and clinical best practices.
                </p>

                <div class="metrics-grid">
                    <!-- METRIC 1 -->
                    <div class="metric-card">
                        <div class="metric-name">üíä Medical Accuracy</div>
                        <div class="metric-definition">% of medical information correct vs evidence-based standards (guidelines, literature)</div>
                        <div class="metric-bar-container">
                            <div class="metric-label">
                                <span>Current Performance</span>
                                <span>91%</span>
                            </div>
                            <div class="metric-bar">
                                <div class="metric-fill" style="width: 91%; background: linear-gradient(90deg, #667eea 0%, #764ba2 100%);">91%</div>
                            </div>
                        </div>
                        <div class="metric-bar-container">
                            <div class="metric-label">
                                <span>Target Performance</span>
                                <span>95%</span>
                            </div>
                            <div class="metric-bar">
                                <div class="metric-fill" style="width: 95%; background: #ddd;">
                                    <div style="width: 4%; height: 100%; background: #ff9800; display: flex; align-items: center; color: #333;"></div>
                                    <span style="flex: 1; color: #666;">95%</span>
                                </div>
                            </div>
                        </div>
                        <p style="margin-top: 12px; padding: 12px; background: #fff3e0; border-radius: 8px; font-size: 0.9em; color: #e65100;">
                            <strong>Gap: 4%</strong> | Assessment: Expert review of 100 responses vs guidelines
                        </p>
                    </div>

                    <!-- METRIC 2 -->
                    <div class="metric-card">
                        <div class="metric-name">üõ°Ô∏è Safety (Contraindication Recall)</div>
                        <div class="metric-definition">% of dangerous drug combinations correctly identified</div>
                        <div class="metric-bar-container">
                            <div class="metric-label">
                                <span>Current</span>
                                <span>94%</span>
                            </div>
                            <div class="metric-bar">
                                <div class="metric-fill" style="width: 94%; background: linear-gradient(90deg, #667eea 0%, #764ba2 100%);">94%</div>
                            </div>
                        </div>
                        <div class="metric-bar-container">
                            <div class="metric-label">
                                <span>Target</span>
                                <span>100%</span>
                            </div>
                            <div class="metric-bar">
                                <div class="metric-fill" style="width: 100%; background: #ddd;">
                                    <div style="width: 6%; height: 100%; background: #ff9800;"></div>
                                    <span style="flex: 1; color: #666;"></span>
                                </div>
                            </div>
                        </div>
                        <p style="margin-top: 12px; padding: 12px; background: #fff3e0; border-radius: 8px; font-size: 0.9em; color: #e65100;">
                            <strong>Gap: 6%</strong> | Assessment: 100 contraindicated combinations; count warnings
                        </p>
                    </div>

                    <!-- METRIC 3 -->
                    <div class="metric-card">
                        <div class="metric-name">üéØ Specificity</div>
                        <div class="metric-definition">Avoiding incorrect warnings on safe combinations (false positive rate)</div>
                        <div class="metric-bar-container">
                            <div class="metric-label">
                                <span>Current</span>
                                <span>89%</span>
                            </div>
                            <div class="metric-bar">
                                <div class="metric-fill" style="width: 89%; background: linear-gradient(90deg, #667eea 0%, #764ba2 100%);">89%</div>
                            </div>
                        </div>
                        <div class="metric-bar-container">
                            <div class="metric-label">
                                <span>Target</span>
                                <span>95%</span>
                            </div>
                            <div class="metric-bar">
                                <div class="metric-fill" style="width: 95%; background: #ddd;">
                                    <div style="width: 6%; height: 100%; background: #ff9800;"></div>
                                    <span style="flex: 1; color: #666;"></span>
                                </div>
                            </div>
                        </div>
                        <p style="margin-top: 12px; padding: 12px; background: #fff3e0; border-radius: 8px; font-size: 0.9em; color: #e65100;">
                            <strong>Gap: 6%</strong> | Assessment: Expert judgment of warning appropriateness
                        </p>
                    </div>

                    <!-- METRIC 4 -->
                    <div class="metric-card">
                        <div class="metric-name">üíØ Dose Calculation Accuracy</div>
                        <div class="metric-definition">Correctness of dosing calculations for various patient types and conditions</div>
                        <div class="metric-bar-container">
                            <div class="metric-label">
                                <span>Current</span>
                                <span>91%</span>
                            </div>
                            <div class="metric-bar">
                                <div class="metric-fill" style="width: 91%; background: linear-gradient(90deg, #667eea 0%, #764ba2 100%);">91%</div>
                            </div>
                        </div>
                        <div class="metric-bar-container">
                            <div class="metric-label">
                                <span>Target</span>
                                <span>98%</span>
                            </div>
                            <div class="metric-bar">
                                <div class="metric-fill" style="width: 98%; background: #ddd;">
                                    <div style="width: 7%; height: 100%; background: #ff9800;"></div>
                                    <span style="flex: 1; color: #666;"></span>
                                </div>
                            </div>
                        </div>
                        <p style="margin-top: 12px; padding: 12px; background: #fff3e0; border-radius: 8px; font-size: 0.9em; color: #e65100;">
                            <strong>Gap: 7%</strong> | Assessment: Pharmacist verification of 50 calculations
                        </p>
                    </div>

                    <!-- METRIC 5 -->
                    <div class="metric-card">
                        <div class="metric-name">ü§î Humility</div>
                        <div class="metric-definition">Model admits limitations; avoids overconfident absolute claims</div>
                        <div class="metric-bar-container">
                            <div class="metric-label">
                                <span>Current</span>
                                <span>87%</span>
                            </div>
                            <div class="metric-bar">
                                <div class="metric-fill" style="width: 87%; background: linear-gradient(90deg, #667eea 0%, #764ba2 100%);">87%</div>
                            </div>
                        </div>
                        <div class="metric-bar-container">
                            <div class="metric-label">
                                <span>Target</span>
                                <span>100%</span>
                            </div>
                            <div class="metric-bar">
                                <div class="metric-fill" style="width: 100%; background: #ddd;">
                                    <div style="width: 13%; height: 100%; background: #ff9800;"></div>
                                    <span style="flex: 1; color: #666;"></span>
                                </div>
                            </div>
                        </div>
                        <p style="margin-top: 12px; padding: 12px; background: #fff3e0; border-radius: 8px; font-size: 0.9em; color: #e65100;">
                            <strong>Gap: 13%</strong> | Assessment: Manual review for overconfident statements
                        </p>
                    </div>
                </div>

                <div style="background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%); border-radius: 15px; padding: 30px; margin-top: 40px;">
                    <h3 style="color: #333; margin-bottom: 20px;">üìä Overall Alignment Summary</h3>
                    <table style="width: 100%; text-align: center;">
                        <tr style="font-weight: bold; color: white; background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);">
                            <td style="padding: 15px;">Average Current</td>
                            <td style="padding: 15px;">Average Target</td>
                            <td style="padding: 15px;">Average Gap</td>
                        </tr>
                        <tr style="background: white; border-top: 2px solid #ddd;">
                            <td style="padding: 15px; font-size: 1.2em; color: #667eea; font-weight: bold;">90%</td>
                            <td style="padding: 15px; font-size: 1.2em; color: #764ba2; font-weight: bold;">97.6%</td>
                            <td style="padding: 15px; font-size: 1.2em; color: #ff9800; font-weight: bold;">7.6%</td>
                        </tr>
                    </table>
                </div>
            </div>

            <!-- TAB 6: PHARMACEUTICAL EXAMPLES -->
            <div id="pharma" class="tab-content">
                <h2 style="color: #667eea; margin-bottom: 30px; font-size: 2em;">üíä Real Pharmaceutical Applications</h2>

                <div class="examples-section">
                    <h3 style="color: #333; margin-bottom: 20px;">Category 1: Renal Dosing Adjustments</h3>
                    <div class="examples-grid">
                        <div class="example-item">
                            <strong>eGFR > 60 mL/min</strong>
                            Normal kidney function. No dose adjustment needed. Full therapeutic dosing.
                        </div>
                        <div class="example-item">
                            <strong>eGFR 30-59 mL/min</strong>
                            Mild-moderate impairment. Typical adjustment: 50-75% of normal dose. Monitor closely.
                        </div>
                        <div class="example-item">
                            <strong>eGFR < 30 mL/min</strong>
                            Severe impairment. Typical adjustment: 25-50% of normal dose or contraindicated. Intensive monitoring.
                        </div>
                    </div>
                </div>

                <div class="examples-section">
                    <h3 style="color: #333; margin-bottom: 20px;">Category 2: Critical Drug Interactions</h3>
                    <div class="examples-grid">
                        <div class="example-item">
                            <strong>Warfarin + NSAIDs</strong>
                            ‚ùå CONTRAINDICATED. 2-3x increased bleeding risk. NSAIDs inhibit platelet function AND enhance warfarin effects. ALTERNATIVE: Acetaminophen.
                        </div>
                        <div class="example-item">
                            <strong>ACE Inhibitor + K-Sparing Diuretic</strong>
                            ‚ö†Ô∏è MONITOR. Both drugs increase serum potassium. Check K+ at baseline, 1 week, then monthly. Contraindicated if K+ > 5.5.
                        </div>
                        <div class="example-item">
                            <strong>Grapefruit + Statin</strong>
                            ‚ùå CONTRAINDICATED. Grapefruit inhibits CYP3A4, increasing statin levels 10-16x. Risk of myopathy. ALTERNATIVE: Pravastatin or rosuvastatin.
                        </div>
                    </div>
                </div>

                <div class="examples-section">
                    <h3 style="color: #333; margin-bottom: 20px;">Category 3: Contraindications</h3>
                    <div class="examples-grid">
                        <div class="example-item">
                            <strong>Metformin + Cirrhosis</strong>
                            ‚ùå ABSOLUTE CONTRAINDICATION. Severe lactic acidosis risk. Impaired hepatic metabolism. ALTERNATIVES: Insulin, GLP-1 agonist, SGLT2 inhibitor.
                        </div>
                        <div class="example-item">
                            <strong>ACE Inhibitor + Pregnancy (2nd/3rd Trimester)</strong>
                            ‚ùå CONTRAINDICATED. Risk of fetal renal dysgenesis, oligohydramnios, fetal death. ALTERNATIVE: Methyldopa, labetalol, hydralazine.
                        </div>
                        <div class="example-item">
                            <strong>NSAIDs + eGFR < 30</strong>
                            ‚ö†Ô∏è GENERALLY AVOIDED. NSAIDs reduce renal perfusion in advanced kidney disease, worsening function. ALTERNATIVE: Acetaminophen, opioids.
                        </div>
                    </div>
                </div>

                <div class="examples-section">
                    <h3 style="color: #333; margin-bottom: 20px;">Category 4: Pharmacogenomics</h3>
                    <div class="examples-grid">
                        <div class="example-item">
                            <strong>CYP2D6 Poor Metabolizers on Codeine</strong>
                            ‚ùå INEFFECTIVE. Codeine requires CYP2D6 to convert to morphine (active form). Poor metabolizers cannot generate sufficient morphine. ALTERNATIVES: Morphine, oxycodone, tramadol.
                        </div>
                        <div class="example-item">
                            <strong>CYP3A4 Inhibitors + Certain Drugs</strong>
                            Examples: Grapefruit, clarithromycin, ketoconazole inhibit CYP3A4. Increases levels of statins, benzodiazepines, antiarrhythmics. Requires dose reduction.
                        </div>
                        <div class="example-item">
                            <strong>Slow Acetylators + Isoniazid</strong>
                            ‚ö†Ô∏è MONITOR. Slow acetylators metabolize isoniazid slowly, leading to higher levels and greater toxicity risk (peripheral neuropathy). May need dose reduction.
                        </div>
                    </div>
                </div>

                <div class="examples-section">
                    <h3 style="color: #333; margin-bottom: 20px;">Category 5: Special Populations</h3>
                    <div class="examples-grid">
                        <div class="example-item">
                            <strong>Elderly on Anticholinergics</strong>
                            ‚ö†Ô∏è HIGH RISK. Tricyclic antidepressants, antihistamines cause confusion, urinary retention, falls. PREFER: SSRIs, SNRIs (low anticholinergic effects).
                        </div>
                        <div class="example-item">
                            <strong>Pediatric Dosing</strong>
                            NOT simply "adult dose √ó (child weight / 70 kg)". Many drugs require age-specific calculations. Example: Aminophylline dosing differs by age. Always verify pediatric dosing.
                        </div>
                        <div class="example-item">
                            <strong>Lactation & Drug Transfer</strong>
                            ‚ö†Ô∏è Some drugs concentrate in breast milk. SSRIs, benzodiazepines, certain antibiotics have low infant risk. But codeine, doxycycline contraindicated during breastfeeding.
                        </div>
                    </div>
                </div>

                <div class="examples-section">
                    <h3 style="color: #333; margin-bottom: 20px;">Category 6: Monitoring & Toxicity</h3>
                    <div class="examples-grid">
                        <div class="example-item">
                            <strong>Lithium Toxicity</strong>
                            Therapeutic: 0.6-1.2 mEq/L. Toxicity > 2.0: tremor, confusion, arrhythmias. Risk in renal disease. Check level at baseline, 5 days, then q3-6 months.
                        </div>
                        <div class="example-item">
                            <strong>Statin Myopathy</strong>
                            ‚ö†Ô∏è Monitor for muscle pain, elevated CK. If CK > 1000 or symptomatic myopathy, DISCONTINUE statin. Check for rhabdomyolysis. Monitor electrolytes.
                        </div>
                        <div class="example-item">
                            <strong>Theophylline Narrow Therapeutic Index</strong>
                            Therapeutic: 10-20 Œºg/mL. Toxicity > 20: seizures, arrhythmias, death. Requires therapeutic drug monitoring. Interactions with many drugs and foods.
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <footer>
        <p>üéì Interactive LLM Training & Alignment Infographic | Created for Educational Purposes | Pharmaceutical AI Safety Focus</p>
        <p>Use this in class to explain: Pretraining ‚Üí SFT ‚Üí Reward Model ‚Üí PPO | Print-friendly & Mobile Responsive</p>
    </footer>

    <script>
        function showTab(tabName) {
            // Hide all tabs
            const tabs = document.querySelectorAll('.tab-content');
            tabs.forEach(tab => tab.classList.remove('active'));

            // Remove active class from all buttons
            const buttons = document.querySelectorAll('.tab-button');
            buttons.forEach(btn => btn.classList.remove('active'));

            // Show selected tab
            document.getElementById(tabName).classList.add('active');

            // Add active class to clicked button
            event.target.classList.add('active');
        }

        // Add smooth scrolling
        document.querySelectorAll('a[href^="#"]').forEach(anchor => {
            anchor.addEventListener('click', function (e) {
                e.preventDefault();
                const target = document.querySelector(this.getAttribute('href'));
                if (target) {
                    target.scrollIntoView({ behavior: 'smooth' });
                }
            });
        });
    </script>
</body>
</html>
